Methyl groups can have profound effects in drug discovery but the underlying mechanisms are diverse and incompletely understood. Here we report the stereospecific effect of a single, solvent-exposed methyl group in bicyclic [4.3.1] aza-amides, robustly leading to a 2 to 10-fold increase in binding affinity for FK506-binding proteins (FKBPs). This resulted in the most potent and efficient FKBP ligands known to date. By a combination of co-crystal structures, isothermal titration calorimetry (ITC), density-functional theory (DFT), and 3D reference interaction site model (3D-RISM) calculations we elucidated the origin of the observed affinity boost, which was purely entropically driven and relied on the displacement of a water molecule at the ...
The FK506-binding protein 51 (FKBP51) has emerged as an attractive new drug target for mood disorder...
To create highly efficient inhibitors for FK506-binding proteins, a new asymmetric synthesis for pro...
The human Hsp90 co-chaperone FKBP52 belongs to the family of FK506-binding proteins, which act as pe...
Methyl groups can have profound effects in drug discovery but the underlying mechanisms are diverse ...
FK506-binding proteins (FKBPs) have emerged as a promising drug target due to their role in various ...
The design of efficient ligands remains a key challenge in drug discovery. In the quest for lead-lik...
In recent years, many members of the FK506-binding protein (FKBP) family were increasingly linked t...
FKBP51 is well-known as a cochaperone of Hsp90 machinery and implicated in many human diseases inclu...
FK506-binding proteins (FKBPs) are evolutionarily conserved proteins that display peptidyl-prolyl is...
FK506-binding proteins (FKBPs) are evolutionarily conserved proteins that display peptidyl-prolyl is...
The design of efficient ligands remains a key challenge in drug discovery. In the quest for lead-lik...
FK506-binding proteins (FKBPs) are evolutionarily conserved proteins that display peptidyl-prolyl is...
The principal aim of this study was to discover, through virtual screening, new nonimmunosuppressive...
The FK506-binding protein 51 (FKBP51) emerged as a key player in several diseases like stress-relate...
The FK506-binding protein 51 (FKBP51) has emerged as an attractive new drug target for mood disorder...
To create highly efficient inhibitors for FK506-binding proteins, a new asymmetric synthesis for pro...
The human Hsp90 co-chaperone FKBP52 belongs to the family of FK506-binding proteins, which act as pe...
Methyl groups can have profound effects in drug discovery but the underlying mechanisms are diverse ...
FK506-binding proteins (FKBPs) have emerged as a promising drug target due to their role in various ...
The design of efficient ligands remains a key challenge in drug discovery. In the quest for lead-lik...
In recent years, many members of the FK506-binding protein (FKBP) family were increasingly linked t...
FKBP51 is well-known as a cochaperone of Hsp90 machinery and implicated in many human diseases inclu...
FK506-binding proteins (FKBPs) are evolutionarily conserved proteins that display peptidyl-prolyl is...
FK506-binding proteins (FKBPs) are evolutionarily conserved proteins that display peptidyl-prolyl is...
The design of efficient ligands remains a key challenge in drug discovery. In the quest for lead-lik...
FK506-binding proteins (FKBPs) are evolutionarily conserved proteins that display peptidyl-prolyl is...
The principal aim of this study was to discover, through virtual screening, new nonimmunosuppressive...
The FK506-binding protein 51 (FKBP51) emerged as a key player in several diseases like stress-relate...
The FK506-binding protein 51 (FKBP51) has emerged as an attractive new drug target for mood disorder...
To create highly efficient inhibitors for FK506-binding proteins, a new asymmetric synthesis for pro...
The human Hsp90 co-chaperone FKBP52 belongs to the family of FK506-binding proteins, which act as pe...